The EU Commission president's attack on the pharmaceutical firm in the supply dispute comes on the day the European Medicines Agency is expected to authorise use of its vaccine.
The EU Commission president's attack on the pharmaceutical firm in the supply dispute comes on the day the European Medicines Agency is expected to authorise use of its vaccine.
The CEO of the British-Swedish pharmaceutical company says the EU signed its contract with the firm three months after the UK did,..